Chronic illness perhaps. Still undeveloped, needing CR and prospects for AA not looking good. Management is dreaming as always. DYOR cheers
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025